DELTA 9 CANNABIS INC (DN.CA) Fundamental Analysis & Valuation

TSX:DN • CA2477541049

Current stock price

0.01 CAD
0 (0%)
Last:

This DN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DN.CA Profitability Analysis

1.1 Basic Checks

  • In the past year DN has reported negative net income.
  • DN had a positive operating cash flow in the past year.
  • DN had negative earnings in 4 of the past 5 years.
  • In multiple years DN reported negative operating cash flow during the last 5 years.
DN.CA Yearly Net Income VS EBIT VS OCF VS FCFDN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

1.2 Ratios

  • With a Return On Assets value of -27.91%, DN is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -27.91%
ROE N/A
ROIC N/A
ROA(3y)-22.78%
ROA(5y)-11.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DN.CA Yearly ROA, ROE, ROICDN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K -1K 1.5K

1.3 Margins

  • Looking at the Gross Margin, with a value of 26.05%, DN is doing worse than 62.86% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DN has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for DN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.62%
GM growth 5Y-0.97%
DN.CA Yearly Profit, Operating, Gross MarginsDN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. DN.CA Health Analysis

2.1 Basic Checks

  • DN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DN has been increased compared to 1 year ago.
  • The debt/assets ratio for DN is higher compared to a year ago.
DN.CA Yearly Shares OutstandingDN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
DN.CA Yearly Total Debt VS Total AssetsDN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -1.60, we must say that DN is in the distress zone and has some risk of bankruptcy.
  • DN has a Altman-Z score (-1.60) which is in line with its industry peers.
  • The Debt to FCF ratio of DN is 15.70, which is on the high side as it means it would take DN, 15.70 years of fcf income to pay off all of its debts.
  • DN's Debt to FCF ratio of 15.70 is fine compared to the rest of the industry. DN outperforms 62.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.7
Altman-Z -1.6
ROIC/WACCN/A
WACC1.49%
DN.CA Yearly LT Debt VS Equity VS FCFDN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

  • DN has a Current Ratio of 0.30. This is a bad value and indicates that DN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DN has a worse Current ratio (0.30) than 91.43% of its industry peers.
  • DN has a Quick Ratio of 0.30. This is a bad value and indicates that DN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DN has a worse Quick ratio (0.09) than 94.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.09
DN.CA Yearly Current Assets VS Current LiabilitesDN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DN.CA Growth Analysis

3.1 Past

  • DN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.33%, which is quite impressive.
  • DN shows a small growth in Revenue. In the last year, the Revenue has grown by 4.44%.
  • DN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 56.50% yearly.
EPS 1Y (TTM)46.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.55%
Revenue 1Y (TTM)4.44%
Revenue growth 3Y10.94%
Revenue growth 5Y56.5%
Sales Q2Q%-2.43%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.96%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DN.CA Yearly Revenue VS EstimatesDN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DN.CA Yearly EPS VS EstimatesDN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 0 0.05 -0.05 0.1

More info and screens

Find the best growth stocksShow best growing peers

2

4. DN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DN.CA Price Earnings VS Forward Price EarningsDN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, DN is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.46
EV/EBITDA N/A
DN.CA Per share dataDN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DN.CA Dividend Analysis

5.1 Amount

  • No dividends for DN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DN.CA Fundamentals: All Metrics, Ratios and Statistics

DELTA 9 CANNABIS INC

TSX:DN (7/15/2024, 7:00:00 PM)

0.01

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-13
Earnings (Next)08-12
Inst Owners0.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.87M
Revenue(TTM)70.65M
Net Income(TTM)-19.60M
Analysts40
Price Target0.06 (500%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 0.46
P/OCF 0.44
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY219.76%
OCF(TTM)0.02
OCFY225.81%
SpS0.38
BVpS-0.05
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -27.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.05%
FCFM 5.82%
ROA(3y)-22.78%
ROA(5y)-11.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.62%
GM growth 5Y-0.97%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.7
Debt/EBITDA N/A
Cap/Depr 1.31%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.09
Altman-Z -1.6
F-Score5
WACC1.49%
ROIC/WACCN/A
Cap/Depr(3y)25.62%
Cap/Depr(5y)116.41%
Cap/Sales(3y)2.93%
Cap/Sales(5y)12.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.44%
Revenue growth 3Y10.94%
Revenue growth 5Y56.5%
Sales Q2Q%-2.43%
Revenue Next Year9.96%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y215.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y526.92%
OCF growth 3Y40.88%
OCF growth 5YN/A

DELTA 9 CANNABIS INC / DN.CA Fundamental Analysis FAQ

What is the fundamental rating for DN stock?

ChartMill assigns a fundamental rating of 2 / 10 to DN.CA.


Can you provide the valuation status for DELTA 9 CANNABIS INC?

ChartMill assigns a valuation rating of 2 / 10 to DELTA 9 CANNABIS INC (DN.CA). This can be considered as Overvalued.


How profitable is DELTA 9 CANNABIS INC (DN.CA) stock?

DELTA 9 CANNABIS INC (DN.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for DN stock?

The financial health rating of DELTA 9 CANNABIS INC (DN.CA) is 1 / 10.